stock ticker: MED

The Real “Skinny” on Medifast (AMEX:MED)

BREAKING NEWS: Just today, the EU approved Drug Giant’s Sanofi-Aventis’s new blockbuster pill for obesity, Acomplia. US Approval is expected in upcoming months and the pill we be available on the internet for consumers within months. This goes directly against Medifast, whose primary diets fight obesity.

(more…)

stock ticker: HOM

Stocklemon.com responds to Home Solutions of America and American Renaissance Homes regarding recent PR’s.

Yesterday and today, Home Solutions of America (AMEX:HOM) and American Renaissance Homes issued Press Releases attempting to “clarify” their business relationship. Stocklemon comments on what has been learned in these communications.

http://biz.yahoo.com/bw/060607/20060607005546.html?.v=1

Stocklemon is delighted to note confirmation of its belief that Alan Nazarro is indeed the Chief Operating Officer of American Renaissance Homes (ARH), as he stated in a phone conversation yesterday. Mr. Nazarro specifically made the ‘40% ownership’ statement yesterday.

(more…)

stock ticker: HOM

O, what a tangled web we weave when first we practice to deceive!

— Sir Walter Scott

Just two short weeks ago, Home Solutions of America (AMEX:HOM) was hitting new highs. On the cusp of the new hurricane season, the market was searching for the next great “hurricane story” stock. That was the precise moment when insiders of HOM were selling their positions in large quantities.

What do they know that you don’t know ?

Is this really a hurricane play, or is it no more than a lot of hot air that hit an updraft of misunderstood news and hysteria? You will not believe what we found out.

(more…)

stock ticker: HOM

Is Home Solutions a Natural Disaster Waiting to Happen? Stocklemon Reports on (Amex:HOM)

What is Home Solutions?

Home Solutions was a dormant company and had no operations during most of 2002. Between then and the present, they have spent $50 million in cheap stock and expensive debt to acquire 5 small building services companies - $1.5 to $16 million apiece. These 5 companies comprise 100% of the present day HOM, which, in an astounding feat of new math, is now conferred a fully diluted market cap of over $440 million!

Over the past year, the stock has made a major move as investors flocked to it as a potential benefactor of the Hurricane Katrina clean-up. Yet, Stocklemon cautions investors, that they not worry about the potential for another hurricane but rather they should be concerned about a tsunami of insider selling and a business model that has an ominous sense of déjà vu’.

(more…)